Patents by Inventor Matthew LaMarche

Matthew LaMarche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EFTU inhibitors or aminothiazoles and their uses
    Patent number: 7851439
    Abstract: Organic compounds that are useful for the treatment, prevention and/or amelioration of diseases are described.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: December 14, 2010
    Assignee: Novartis AG
    Inventors: Simon Bushell, Matthew LaMarche, Michael J. Patane, Lewis Whitehead
  • Bicyclic compounds with kinase inhibitory activity
    Publication number: 20070149533
    Abstract: The present invention provides novel bicyclic compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
    Type: Application
    Filed: December 7, 2006
    Publication date: June 28, 2007
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Emily Calderwood, Matthew Duffey, Alexandra Gould, Paul Greenspan, Bheemashankar Kulkarni, Matthew LaMarche, Robyn Rowland, Ming Tregay, Tricia Vos
  • Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
    Publication number: 20070043223
    Abstract: Synthetic methods and intermediates useful in the preparation of lactone containing compounds such as discodermolide and compounds which mimic the chemical or biological activity of discodermolide are provided.
    Type: Application
    Filed: July 13, 2006
    Publication date: February 22, 2007
    Inventors: Amos Smith, Thomas Beauchamp, Matthew LaMarche
  • Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
    Publication number: 20060160803
    Abstract: The present invention provides novel cinnamide compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
    Type: Application
    Filed: January 12, 2006
    Publication date: July 20, 2006
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Ruth Adams, Emily Calderwood, Alexandra Gould, Paul Greenspan, Matthew LaMarche, Yuan Tian, Tricia Vos
  • Chk-1 inhibitors
    Publication number: 20060035920
    Abstract: Disclosed are novel inhibitors of Chk-1 and methods of using the same for therapy.
    Type: Application
    Filed: May 27, 2005
    Publication date: February 16, 2006
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Robert Boyle, Hassan Imogai, Michael Cherry, Alfred Humphries, Eva Navarro, David Owen, Natalie Dales, Matthew LaMarche, Courtney Cullis, Alexandra Gould, Paul Greenspan
  • Chk-1 inhibitors
    Publication number: 20050245563
    Abstract: Disclosed are novel inhibitors of Chk-1 and methods of using the same for therapy.
    Type: Application
    Filed: May 28, 2004
    Publication date: November 3, 2005
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Robert Boyle, Hassan Imogai, Michael Cherry, Alfred Humphries, Eva Navarro, David Owen, Natalie Dales, Matthew LaMarche, Courtney Cullis, Alexandra Gould